Announcing the roll-out of the innovative new community project NIHR Collaboration for Leadership in Applied Health Research and Care Northwest London (CLAHRC NWL) , Chelsea and Westminster Hospitals NHS Foundation Trust, Hounslow Clinical Commissioning Group and the Arrhythmia Alliance which is set to reduce the risk of a stroke for Hounslow residents.
The project, funded by NIHR CLAHRC NWL and Hounslow CCG and is supported by several industry partners including Samsung and EE, aims to improve the detection and treatment of an abnormal heart rhythm, Atrial Fibrillation (AF), which affects 1 in 4 people over the age of 40 and causes 1 in 5 strokes.
The Hounslow Community Atrial Fibrillation (AF) Project is designed to improve the detection and treatment of AF which may not cause any symptoms. A portable ECG monitor called Kardia® Mobile (developed by AliveCor Ltd) which captures a single lead heart trace over 30 seconds is used to detect AF, to improve choice and speed of treatment. The project has been successfully piloted since February in 5 GP practices within Hounslow and has now been rolled out to all GP surgeries in the Hounslow CCG area.
A West Middlesex patient had a history of occasional palpitations of the heart but struggled to find a diagnosis. Mr Pickles did not want to go down the route of a Holter monitor, a portable device worn continuously for at least 24 hours to monitor heart rhythm, and instead bought his own Kardia® Mobile ECG, which links with his smart phone.
The roll-out of the project is timely as on June 17th Simon Stevens, Chief Executive of NHS England announced a new tariff for medical technology devices from April 2017 in a keynote address at the NHS Confederation Annual Conference in Manchester. Clearly primary care in Hounslow has already embraced this as a concept and are looking forward to seeing the benefits for Hounslow residents.
For more information visit our website: http://clahrc-northwestlondon.nihr.ac.uk/home
Notes to editors
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. The NIHR is the research arm of the NHS. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk).